WASh multicentre randomised controlled trial: water-assisted sigmoidoscopy in English NHS bowel scope screening. Issue 5 (7th September 2020)
- Record Type:
- Journal Article
- Title:
- WASh multicentre randomised controlled trial: water-assisted sigmoidoscopy in English NHS bowel scope screening. Issue 5 (7th September 2020)
- Main Title:
- WASh multicentre randomised controlled trial: water-assisted sigmoidoscopy in English NHS bowel scope screening
- Authors:
- Rutter, Matthew D
Evans, Rachel
Hoare, Zoe
Von Wagner, Christian
Deane, Jill
Esmaily, Shiran
Larkin, Tony
Edwards, Rhiannon
Yeo, Seow Tien
Spencer, Llinos Haf
Holmes, Emily
Saunders, Brian P
Rees, Colin J
Tsiamoulos, Zacharias P
Beintaris, Iosif - Other Names:
- author non-byline.
Bramble Mike author non-byline.
Dhar Anjan author non-byline.
Riley Stuart author non-byline.
Larkin Tony author non-byline.
Whyte Sophie author non-byline.
Kasim Adetayo author non-byline.
Veitch Andrew author non-byline.
Chilton Andrew author non-byline.
Williams Ben Carter; Lynne author non-byline.
Greenaway Jane author non-byline.
Carter Justin author non-byline.
Collins Vicky author non-byline.
Westwood Clare author non-byline.
Lee Tom author non-byline.
Crane Sarah author non-byline.
MacBain James author non-byline.
Lawrence Catherine author non-byline. - Abstract:
- Abstract : Objectives: The English Bowel Cancer Screening Programme invites 55 year olds for a sigmoidoscopy (Bowel Scope Screening (BSS)), aiming to resect premalignant polyps, thus reducing cancer incidence. A national patient survey indicated higher procedural pain than anticipated, potentially impacting on screening compliance and effectiveness. We aimed to assess whether water-assisted sigmoidoscopy (WAS), as opposed to standard CO2 technique, improved procedural pain and detection of adenomatous polyps. Design: The WASh (Water-Assisted Sigmoidoscopy) trial was a multicentre, single-blind, randomised control trial for people undergoing BSS. Participants were randomised to either receive WAS or CO2 from five sites across England. The primary outcome measure was patient-reported moderate/severe pain, as assessed by patients on a standard Likert scale post procedure prior to discharge. The key secondary outcome was adenoma detection rate (ADR). The costs of each technique were also measured. Results: 1123 participants (50% women, mean age 55) were randomised (561 WAS, 562 CO2 ). We found no difference in patient-reported moderate/severe pain between WAS and CO2 (14% in WAS, 15% in CO2; p=0.47). ADR was 15% in the CO2 arm and 11% in the WAS arm (p=0.03); however, it remained above the minimum national performance standard in both arms. There was no statistical difference in mean number of adenomas nor overall polyp detection rate. There was negligible cost differenceAbstract : Objectives: The English Bowel Cancer Screening Programme invites 55 year olds for a sigmoidoscopy (Bowel Scope Screening (BSS)), aiming to resect premalignant polyps, thus reducing cancer incidence. A national patient survey indicated higher procedural pain than anticipated, potentially impacting on screening compliance and effectiveness. We aimed to assess whether water-assisted sigmoidoscopy (WAS), as opposed to standard CO2 technique, improved procedural pain and detection of adenomatous polyps. Design: The WASh (Water-Assisted Sigmoidoscopy) trial was a multicentre, single-blind, randomised control trial for people undergoing BSS. Participants were randomised to either receive WAS or CO2 from five sites across England. The primary outcome measure was patient-reported moderate/severe pain, as assessed by patients on a standard Likert scale post procedure prior to discharge. The key secondary outcome was adenoma detection rate (ADR). The costs of each technique were also measured. Results: 1123 participants (50% women, mean age 55) were randomised (561 WAS, 562 CO2 ). We found no difference in patient-reported moderate/severe pain between WAS and CO2 (14% in WAS, 15% in CO2; p=0.47). ADR was 15% in the CO2 arm and 11% in the WAS arm (p=0.03); however, it remained above the minimum national performance standard in both arms. There was no statistical difference in mean number of adenomas nor overall polyp detection rate. There was negligible cost difference between the two techniques. Conclusion: In the context of enema-prepared unsedated screening sigmoidoscopies performed by screening-accredited endoscopists, no difference in patient-reported pain was seen when using either a CO2 or WAS intubation technique. Trial registration number: ISRCTN81466870 . … (more)
- Is Part Of:
- Gut. Volume 70:Issue 5(2021)
- Journal:
- Gut
- Issue:
- Volume 70:Issue 5(2021)
- Issue Display:
- Volume 70, Issue 5 (2021)
- Year:
- 2021
- Volume:
- 70
- Issue:
- 5
- Issue Sort Value:
- 2021-0070-0005-0000
- Page Start:
- 845
- Page End:
- 852
- Publication Date:
- 2020-09-07
- Subjects:
- colorectal neoplasia -- colorectal cancer screening -- gastrointesinal endoscopy -- clinical trials
Gastroenterology -- Periodicals
616.33 - Journal URLs:
- http://gut.bmjjournals.com ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/gutjnl-2020-321918 ↗
- Languages:
- English
- ISSNs:
- 0017-5749
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17176.xml